BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38380947)

  • 1. POLR2A Mutation is a Poor Prognostic Marker of Cerebellopontine Angle Meningioma.
    Okano A; Miyawaki S; Teranishi Y; Hongo H; Dofuku S; Ohara K; Sakai Y; Shin M; Nakatomi H; Saito N
    Neurosurgery; 2024 Feb; ():. PubMed ID: 38380947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and outcomes of facial nerve-sparing treatment approach to cerebellopontine angle meningiomas.
    D'Amico RS; Banu MA; Petridis P; Bercow AS; Malone H; Praver M; Wang TJC; Isaacson SR; Sisti MB
    J Neurosurg; 2017 Dec; 127(6):1231-1241. PubMed ID: 28186449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic characterization and mutational profiling of foramen magnum meningiomas: a multi-institutional study.
    Hua L; Alkhatib M; Fujio S; Alhasan B; Herold S; Zeugner S; Zolal A; Hijazi MM; Clark VE; Wakimoto H; Shankar GM; Brastianos PK; Barker FG; Cahill DP; Ren L; Eyüpoglu IY; Gong Y; Schackert G; Juratli TA
    J Neurosurg; 2024 Jan; ():1-7. PubMed ID: 38277657
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Sakai Y; Miyawaki S; Teranishi Y; Okano A; Ohara K; Hongo H; Ishigami D; Shimada D; Mitsui J; Nakatomi H; Saito N
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804955
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Associations of pathological diagnosis and genetic abnormalities in meningiomas with the embryological origins of the meninges.
    Okano A; Miyawaki S; Hongo H; Dofuku S; Teranishi Y; Mitsui J; Tanaka M; Shin M; Nakatomi H; Saito N
    Sci Rep; 2021 Mar; 11(1):6987. PubMed ID: 33772057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent AKT1E17K mutations in skull base meningiomas are associated with mTOR and ERK1/2 activation and reduced time to tumor recurrence.
    Yesilöz Ü; Kirches E; Hartmann C; Scholz J; Kropf S; Sahm F; Nakamura M; Mawrin C
    Neuro Oncol; 2017 Aug; 19(8):1088-1096. PubMed ID: 28482067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new amplicon-based gene panel for next generation sequencing characterization of meningiomas.
    Mawrin C; Koch R; Waldt N; Sandalcioglu IE; Braunsdorf WEK; Warnke JP; Goehre F; Meisel HJ; Ewald C; Neyazi S; Schüller U; Kirches E
    Brain Pathol; 2022 Mar; 32(2):e13046. PubMed ID: 35213080
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meningioma: Molecular Updates from the 2021 WHO Classification of CNS Tumors and Imaging Correlates.
    Soni N; Ora M; Bathla G; Szekeres D; Desai A; Pillai J; Agarwal A
    AJNR Am J Neuroradiol; 2024 Jun; ():. PubMed ID: 38844366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas.
    Clark VE; Harmancı AS; Bai H; Youngblood MW; Lee TI; Baranoski JF; Ercan-Sencicek AG; Abraham BJ; Weintraub AS; Hnisz D; Simon M; Krischek B; Erson-Omay EZ; Henegariu O; Carrión-Grant G; Mishra-Gorur K; Durán D; Goldmann JE; Schramm J; Goldbrunner R; Piepmeier JM; Vortmeyer AO; Günel JM; Bilgüvar K; Yasuno K; Young RA; Günel M
    Nat Genet; 2016 Oct; 48(10):1253-9. PubMed ID: 27548314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SMO mutation status defines a distinct and frequent molecular subgroup in olfactory groove meningiomas.
    Boetto J; Bielle F; Sanson M; Peyre M; Kalamarides M
    Neuro Oncol; 2017 Mar; 19(3):345-351. PubMed ID: 28082415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole-Exome Sequencing Reveals Recurrent but Heterogeneous Mutational Profiles in Sporadic WHO Grade 1 Meningiomas.
    González-Tablas M; Prieto C; Arandia D; Jara-Acevedo M; Otero Á; Pascual D; Ruíz L; Álvarez-Twose I; García-Montero AC; Orfao A; Tabernero MD
    Front Oncol; 2021; 11():740782. PubMed ID: 34868937
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical evolution of meningiomatosis after discontinuation of cyproterone acetate: clinical cases and histomolecular characterization.
    Passeri T; Giammattei L; Le Van T; Abbritti R; Perrier A; Wong J; Bourneix C; Polivka M; Adle-Biassette H; Bernat AL; Masliah-Planchon J; Mandonnet E; Froelich S
    Acta Neurochir (Wien); 2022 Jan; 164(1):255-263. PubMed ID: 34613529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgically resected skull base meningiomas demonstrate a divergent postoperative recurrence pattern compared with non-skull base meningiomas.
    Mansouri A; Klironomos G; Taslimi S; Kilian A; Gentili F; Khan OH; Aldape K; Zadeh G
    J Neurosurg; 2016 Aug; 125(2):431-40. PubMed ID: 26722844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of hearing functional outcome following surgery for cerebellopontine angle meningioma.
    Fatima N; Maxwell AK; La Dine A; Barnard ZR; Mehta GU; Wilkinson EP; Brackmann DE; Slattery WH; Lekovic GP
    J Neurooncol; 2022 Mar; 157(1):165-176. PubMed ID: 35113287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Simpson grading in meningioma surgery: does the tumor location influence the prognostic value?
    Voß KM; Spille DC; Sauerland C; Suero Molina E; Brokinkel C; Paulus W; Stummer W; Holling M; Jeibmann A; Brokinkel B
    J Neurooncol; 2017 Jul; 133(3):641-651. PubMed ID: 28527009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlations between genomic subgroup and clinical features in a cohort of more than 3000 meningiomas.
    Youngblood MW; Duran D; Montejo JD; Li C; Omay SB; Özduman K; Sheth AH; Zhao AY; Tyrtova E; Miyagishima DF; Fomchenko EI; Hong CS; Clark VE; Riche M; Peyre M; Boetto J; Sohrabi S; Koljaka S; Baranoski JF; Knight J; Zhu H; Pamir MN; Avşar T; Kilic T; Schramm J; Timmer M; Goldbrunner R; Gong Y; Bayri Y; Amankulor N; Hamilton RL; Bilguvar K; Tikhonova I; Tomak PR; Huttner A; Simon M; Krischek B; Kalamarides M; Erson-Omay EZ; Moliterno J; Günel M
    J Neurosurg; 2019 Oct; 133(5):1345-1354. PubMed ID: 31653806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-NF2 mutations have a key effect on inhibitory immune checkpoints and tumor pathogenesis in skull base meningiomas.
    Hao S; Huang G; Feng J; Li D; Wang K; Wang L; Wu Z; Wan H; Zhang L; Zhang J
    J Neurooncol; 2019 Aug; 144(1):11-20. PubMed ID: 31177425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histomolecular characterization of intracranial meningiomas developed in patients exposed to high-dose cyproterone acetate: an antiandrogen treatment.
    Portet S; Naoufal R; Tachon G; Simonneau A; Chalant A; Naar A; Milin S; Bataille B; Karayan-Tapon L
    Neurooncol Adv; 2019; 1(1):vdz003. PubMed ID: 32642646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical impact of targeted amplicon sequencing for meningioma as a practical clinical-sequencing system.
    Yuzawa S; Nishihara H; Yamaguchi S; Mohri H; Wang L; Kimura T; Tsuda M; Tanino M; Kobayashi H; Terasaka S; Houkin K; Sato N; Tanaka S
    Mod Pathol; 2016 Jul; 29(7):708-16. PubMed ID: 27102344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain Invasion and Trends in Molecular Research on Meningioma.
    Go KO; Kim YZ
    Brain Tumor Res Treat; 2023 Jan; 11(1):47-58. PubMed ID: 36762808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.